A panel of biomarkers including caspase-3 and D-dimer may differentiate acute stroke from stroke-mimicking conditions in the emergency department
Open Access
- 24 November 2010
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 270 (2), 166-174
- https://doi.org/10.1111/j.1365-2796.2010.02329.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Medical management of acute intracerebral hemorrhageCurrent Opinion in Critical Care, 2009
- Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma BiomarkersStroke, 2008
- Distinguishing Between Stroke and Mimic at the BedsideStroke, 2006
- Blood Pressure Management in Acute Intracerebral HemorrhageStroke, 2004
- Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic StrokeArchives of Neurology, 2004
- Misdiagnosis of stroke in tissue plasminogen activator–treated patients: Characteristics and outcomesAnnals of Emergency Medicine, 2003
- Lifetime Cost of Stroke in the United StatesStroke, 1996
- Conditions That Mimic Stroke-ReplyArchives of Neurology, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993